The third quarterly (January-March) earnings of Ambee Pharmaceuticals Ltd plunged by 60%.
In a filing with Dhaka Stock Exchange on Wednesday, the company said that its earnings per share (EPS) was Tk0.30 for the Q3 of 2021 as against Tk0.75 for the same period of the previous financial year.
Meanwhile, its net asset value (NAV) per share was Tk23.25 as of March 31, 2021, and Tk24.10 as of June 30, 2020.
Back in the year 2020, Ambee Pharmaceuticals offered a 15% cash dividend to its shareholders. The closing price for each of its shares was Tk454.1 during Wednesday’s trade.
